Nalaganje...

Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity

Heat shock protein (HSP)-based anticancer vaccines have undergone successful preclinical testing and are now entering clinical trial. Questions still remain, however regarding the immunological properties of HSPs. It is now accepted that many of the HSPs participate in tumor immunity, at least in pa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Calderwood, Stuart K., Murshid, Ayesha, Gong, Jianlin
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Research Foundation 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3342006/
https://ncbi.nlm.nih.gov/pubmed/22566956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2012.00075
Oznake: Označite
Brez oznak, prvi označite!